Share Price and Basic Stock Data
Last Updated: December 15, 2025, 3:36 pm
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Alchemist Corporation Ltd operates in the chemicals industry, particularly focusing on inorganic products. As of the latest reported data, the company’s stock price stood at ₹26.3 with a market capitalization of ₹12.9 Cr. The revenue trends indicate a concerning stagnation, with reported sales of ₹0.00 across several quarters from June 2022 to September 2024, reflecting a lack of operational activity or revenue generation. This trend of zero sales persisted through the last reported periods, raising questions about the company’s operational capabilities and market demand for its products. Over the years, the company has recorded minimal sales, with the highest historical figure being ₹0.46 Cr in March 2021. The lack of revenue generation coupled with stagnant sales is alarming, particularly as competitors in the chemicals sector typically demonstrate more robust revenue streams. The absence of sales may also be contributing to a declining investor interest, as evidenced by the company’s inability to attract foreign or domestic institutional investors.
Profitability and Efficiency Metrics
Alchemist Corporation has experienced ongoing challenges in profitability, as illustrated by its net profit figures. For the fiscal year ending March 2025, the net profit recorded was a loss of ₹0.27 Cr, following a similar negative trend in previous years, including a loss of ₹1.62 Cr in March 2022. The operating profit margin (OPM) consistently remained negative, indicating that the company has not been able to convert its revenues into profit effectively. Furthermore, the interest coverage ratio (ICR) stood at -3.08x, highlighting the company’s struggle to meet its interest obligations from its operational earnings. Return on equity (ROE) was reported at 9.02%, while return on capital employed (ROCE) was lower at 7.45%, suggesting that while the equity base is generating some returns, the overall efficiency in capital utilization remains suboptimal. The lack of operational income is exacerbated by high expenses, which totaled ₹1.31 Cr for the fiscal year ended March 2025, signaling inefficiencies in cost management.
Balance Sheet Strength and Financial Ratios
The balance sheet of Alchemist Corporation reveals a precarious financial position, characterized by negative reserves of ₹4.48 Cr as of March 2025. This decline in reserves indicates that the company has not retained sufficient earnings to support its operations or growth. The company reported zero borrowings, which may suggest a conservative financing approach; however, it raises concerns about the lack of leverage to support growth initiatives. The price-to-book value ratio stood at 10.18x, indicating that investors are valuing the company at a significantly higher multiple than the book value per share of ₹1.13. The current ratio was reported at 1.72, suggesting that the company can cover its short-term liabilities comfortably, but the overall risk profile remains elevated due to the negative net worth. The total debt-to-equity ratio was reported at 1.28, indicating a reliance on equity financing, which may limit growth opportunities if operational performance does not improve.
Shareholding Pattern and Investor Confidence
Alchemist Corporation’s shareholding pattern reflects a strong promoter presence, with promoters holding 74.11% of the company’s shares, providing a degree of stability and control. The public holds 25.88% of the shares, with a total of 1,601 shareholders as of the latest report. The consistent promoter stake may signal confidence in the company’s long-term prospects, despite the current operational challenges. However, the lack of foreign institutional investors (FIIs) and domestic institutional investors (DIIs) indicates a potential lack of external confidence in the company’s strategic direction and financial health. Over the reported periods, the number of shareholders has fluctuated, peaking at 1,745 in March 2024 but declining to 1,601 by September 2025. This decrease may be indicative of waning investor interest or confidence in the company’s ability to turn its fortunes around amidst ongoing operational stagnation.
Outlook, Risks, and Final Insight
Looking ahead, Alchemist Corporation faces significant challenges that could hinder any potential recovery. The persistent lack of revenue generation raises concerns about the company’s operational viability and market competitiveness. The negative profitability metrics, including declining net profits and a negative interest coverage ratio, suggest that without a turnaround strategy, the company may continue to struggle financially. On the other hand, the strong promoter holding could provide a foundation for potential restructuring or strategic shifts aimed at revitalizing the business. It is crucial for the management to address operational inefficiencies and explore avenues for revenue diversification. The risks remain substantial, including market volatility and potential regulatory challenges in the chemicals sector. Overall, while the company has inherent strengths, including a solid equity base, the path to recovery will require decisive action and a clear strategic vision to restore investor confidence and operational performance.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Fischer Medical Ventures Ltd | 2,778 Cr. | 43.0 | 125/40.8 | 138 | 5.55 | 0.01 % | 1.08 % | 0.70 % | 1.00 |
| Emmessar Biotech & Nutrition Ltd | 14.6 Cr. | 29.1 | 47.2/25.8 | 63.3 | 16.0 | 0.00 % | 12.6 % | 4.23 % | 10.0 |
| Cochin Minerals & Rutile Ltd | 227 Cr. | 290 | 356/238 | 13.5 | 211 | 2.76 % | 23.3 % | 15.0 % | 10.0 |
| Archean Chemical Industries Ltd | 6,537 Cr. | 529 | 728/408 | 31.9 | 157 | 0.57 % | 16.0 % | 12.0 % | 2.00 |
| Alufluoride Ltd | 335 Cr. | 428 | 515/376 | 16.3 | 144 | 0.70 % | 23.6 % | 20.8 % | 10.0 |
| Industry Average | 5,073.75 Cr | 557.31 | 157.51 | 160.00 | 0.46% | 13.95% | 10.65% | 7.00 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Expenses | 0.03 | 0.03 | 0.03 | 0.09 | 0.04 | 0.04 | 0.04 | 0.12 | 0.05 | 0.09 | 0.05 | 1.14 | 0.05 |
| Operating Profit | -0.03 | -0.03 | -0.03 | -0.09 | -0.04 | -0.04 | -0.04 | -0.12 | -0.05 | -0.09 | -0.05 | -1.14 | -0.05 |
| OPM % | |||||||||||||
| Other Income | 0.02 | 0.03 | -0.06 | 0.00 | 0.00 | 0.00 | 0.00 | 0.43 | 0.03 | 0.03 | 0.03 | 1.03 | 0.00 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | 0.02 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | -0.01 | 0.00 | -0.09 | -0.09 | -0.04 | -0.07 | -0.06 | 0.29 | -0.04 | -0.08 | -0.03 | -0.13 | -0.05 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 17.24% | 0.00% | 0.00% | 0.00% | 0.00% | 60.00% | |
| Net Profit | -0.01 | 0.00 | -0.09 | -0.09 | -0.04 | -0.07 | -0.06 | 0.24 | -0.04 | -0.08 | -0.03 | -0.13 | -0.07 |
| EPS in Rs | -0.02 | 0.00 | -0.18 | -0.18 | -0.08 | -0.14 | -0.12 | 0.49 | -0.08 | -0.16 | -0.06 | -0.28 | -0.14 |
Last Updated: August 20, 2025, 12:10 am
Below is a detailed analysis of the quarterly data for Alchemist Corporation Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Expenses, as of Jun 2025, the value is 0.05 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1.14 Cr. (Mar 2025) to 0.05 Cr., marking a decrease of 1.09 Cr..
- For Operating Profit, as of Jun 2025, the value is -0.05 Cr.. The value appears strong and on an upward trend. It has increased from -1.14 Cr. (Mar 2025) to -0.05 Cr., marking an increase of 1.09 Cr..
- For OPM %, as of Jun 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00%.
- For Other Income, as of Jun 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1.03 Cr. (Mar 2025) to 0.00 Cr., marking a decrease of 1.03 Cr..
- For Interest, as of Jun 2025, the value is 0.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.02 Cr. (Mar 2025) to 0.00 Cr., marking a decrease of 0.02 Cr..
- For Depreciation, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Profit before tax, as of Jun 2025, the value is -0.05 Cr.. The value appears strong and on an upward trend. It has increased from -0.13 Cr. (Mar 2025) to -0.05 Cr., marking an increase of 0.08 Cr..
- For Tax %, as of Jun 2025, the value is 60.00%. The value appears to be increasing, which may not be favorable. It has increased from 0.00% (Mar 2025) to 60.00%, marking an increase of 60.00%.
- For Net Profit, as of Jun 2025, the value is -0.07 Cr.. The value appears strong and on an upward trend. It has increased from -0.13 Cr. (Mar 2025) to -0.07 Cr., marking an increase of 0.06 Cr..
- For EPS in Rs, as of Jun 2025, the value is -0.14. The value appears strong and on an upward trend. It has increased from -0.28 (Mar 2025) to -0.14, marking an increase of 0.14.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:16 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.00 | 0.00 | 0.34 | 0.00 | 0.40 | 0.34 | 0.34 | 0.46 | 0.05 | 0.00 | 0.00 | 0.00 | 0.00 |
| Expenses | 0.12 | 0.10 | 0.60 | 0.28 | 1.66 | 0.27 | 0.29 | 0.31 | 0.24 | 0.18 | 0.24 | 1.31 | 1.29 |
| Operating Profit | -0.12 | -0.10 | -0.26 | -0.28 | -1.26 | 0.07 | 0.05 | 0.15 | -0.19 | -0.18 | -0.24 | -1.31 | -1.29 |
| OPM % | -76.47% | -315.00% | 20.59% | 14.71% | 32.61% | -380.00% | |||||||
| Other Income | -0.07 | -0.02 | 0.03 | -0.38 | 1.30 | 0.01 | 0.00 | -2.04 | -1.42 | 0.00 | 0.43 | 1.11 | 1.06 |
| Interest | 0.01 | 0.01 | 0.01 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.07 | 0.07 | 0.03 |
| Depreciation | 0.01 | 0.02 | 0.01 | 0.01 | 0.04 | 0.03 | 0.03 | 0.03 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | -0.21 | -0.15 | -0.25 | -0.67 | -0.01 | 0.05 | 0.02 | -1.92 | -1.62 | -0.18 | 0.12 | -0.27 | -0.26 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | -100.00% | 0.00% | 50.00% | 0.00% | 0.00% | 0.00% | 41.67% | 0.00% | |
| Net Profit | -0.21 | -0.14 | -0.25 | -0.67 | 0.00 | 0.04 | 0.02 | -1.91 | -1.62 | -0.18 | 0.07 | -0.27 | -0.28 |
| EPS in Rs | -0.43 | -0.28 | -0.51 | -1.36 | 0.00 | 0.08 | 0.04 | -3.89 | -3.30 | -0.37 | 0.14 | -0.57 | -0.58 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 33.33% | -78.57% | -168.00% | 100.00% | -50.00% | -9650.00% | 15.18% | 88.89% | 138.89% | -485.71% |
| Change in YoY Net Profit Growth (%) | 0.00% | -111.90% | -89.43% | 268.00% | -150.00% | -9600.00% | 9665.18% | 73.71% | 50.00% | -624.60% |
Alchemist Corporation Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 10 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | -19% |
| TTM: | -557% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 29% |
| 3 Years: | 35% |
| 1 Year: | 71% |
| Return on Equity | |
|---|---|
| 10 Years: | -1% |
| 5 Years: | -1% |
| 3 Years: | -1% |
| Last Year: | -3% |
Last Updated: September 5, 2025, 2:11 pm
Balance Sheet
Last Updated: December 4, 2025, 2:20 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 4.91 | 4.91 | 4.91 | 4.91 | 4.91 | 4.91 | 4.91 | 4.91 | 4.91 | 4.91 | 4.91 | 4.91 | 4.91 |
| Reserves | 15.29 | 15.11 | 14.84 | 14.16 | 14.17 | 14.22 | 14.25 | 12.34 | 10.72 | 10.54 | 10.95 | -4.36 | -4.48 |
| Borrowings | 0.00 | 0.00 | 0.39 | 0.39 | 0.38 | 0.38 | 0.38 | 0.31 | 0.21 | 0.55 | 0.60 | 0.71 | 0.00 |
| Other Liabilities | 6.89 | 5.61 | 5.68 | 2.57 | 1.71 | 1.75 | 1.68 | 1.79 | 1.63 | 1.61 | 1.34 | 0.07 | 0.19 |
| Total Liabilities | 27.09 | 25.63 | 25.82 | 22.03 | 21.17 | 21.26 | 21.22 | 19.35 | 17.47 | 17.61 | 17.80 | 1.33 | 0.62 |
| Fixed Assets | 15.19 | 15.15 | 15.11 | 15.08 | 15.05 | 15.02 | 14.99 | 14.96 | 14.76 | 14.76 | 14.76 | 0.00 | 0.00 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 4.78 | 4.78 | 4.78 | 2.98 | 2.98 | 2.98 | 2.98 | 2.98 | 1.27 | 1.27 | 1.61 | 0.02 | 0.02 |
| Other Assets | 7.12 | 5.70 | 5.93 | 3.97 | 3.14 | 3.26 | 3.25 | 1.41 | 1.44 | 1.58 | 1.43 | 1.31 | 0.60 |
| Total Assets | 27.09 | 25.63 | 25.82 | 22.03 | 21.17 | 21.26 | 21.22 | 19.35 | 17.47 | 17.61 | 17.80 | 1.33 | 0.62 |
Below is a detailed analysis of the balance sheet data for Alchemist Corporation Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 4.91 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 4.91 Cr..
- For Reserves, as of Sep 2025, the value is -4.48 Cr.. The value appears to be worsening (becoming more negative). It has deteriorated from -4.36 Cr. (Mar 2025) to -4.48 Cr., marking a decline of 0.12 Cr..
- For Borrowings, as of Sep 2025, the value is 0.00 Cr.. The value appears to be improving (decreasing). However, Reserves are negative, which is a major warning sign. It has decreased from 0.71 Cr. (Mar 2025) to 0.00 Cr., marking a decrease of 0.71 Cr..
- For Other Liabilities, as of Sep 2025, the value is 0.19 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.07 Cr. (Mar 2025) to 0.19 Cr., marking an increase of 0.12 Cr..
- For Total Liabilities, as of Sep 2025, the value is 0.62 Cr.. The value appears to be improving (decreasing). It has decreased from 1.33 Cr. (Mar 2025) to 0.62 Cr., marking a decrease of 0.71 Cr..
- For Fixed Assets, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 0.02 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.02 Cr..
- For Other Assets, as of Sep 2025, the value is 0.60 Cr.. The value appears to be declining and may need further review. It has decreased from 1.31 Cr. (Mar 2025) to 0.60 Cr., marking a decrease of 0.71 Cr..
- For Total Assets, as of Sep 2025, the value is 0.62 Cr.. The value appears to be declining and may need further review. It has decreased from 1.33 Cr. (Mar 2025) to 0.62 Cr., marking a decrease of 0.71 Cr..
However, the Borrowings (0.00 Cr.) are higher than the Reserves (-4.48 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -0.12 | -0.10 | -0.65 | -0.67 | -1.64 | -0.31 | -0.33 | -0.16 | -0.40 | -0.73 | -0.84 | -2.02 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 4,573.24 | 2,162.62 | 2,544.26 | 2,254.41 | 0.00 | 0.00 | ||||||
| Inventory Days | 1,233.11 | 0.00 | ||||||||||
| Days Payable | 4,281.35 | |||||||||||
| Cash Conversion Cycle | 1,524.99 | 2,162.62 | 2,544.26 | 2,254.41 | 0.00 | 0.00 | ||||||
| Working Capital Days | 128.82 | 1,213.62 | 1,545.88 | 1,610.29 | -372.93 | -1,825.00 | ||||||
| ROCE % | -0.64% | -0.55% | -1.19% | -1.31% | 0.00% | 0.26% | 0.10% | 0.65% | -1.14% | -1.13% | 1.17% | -2.25% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | -0.57 | 0.13 | -0.37 | -3.29 | -3.89 |
| Diluted EPS (Rs.) | -0.57 | 0.13 | -0.37 | -3.29 | -3.89 |
| Cash EPS (Rs.) | -0.54 | 0.13 | -0.36 | -3.27 | -3.84 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 1.13 | 2.39 | 1.56 | 1.93 | 4.75 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 1.13 | 32.28 | 31.45 | 31.82 | 35.11 |
| Revenue From Operations / Share (Rs.) | 0.00 | 0.00 | 0.00 | 0.11 | 0.93 |
| PBDIT / Share (Rs.) | -0.41 | 0.36 | -0.36 | 0.22 | 0.31 |
| PBIT / Share (Rs.) | -0.41 | 0.36 | -0.36 | 0.19 | 0.26 |
| PBT / Share (Rs.) | -0.54 | 0.23 | -0.36 | -3.29 | -3.90 |
| Net Profit / Share (Rs.) | -0.54 | 0.13 | -0.36 | -3.29 | -3.89 |
| NP After MI And SOA / Share (Rs.) | -0.56 | 0.13 | -0.36 | -3.29 | -3.89 |
| PBDIT Margin (%) | 0.00 | 0.00 | -12020.00 | 191.22 | 33.58 |
| PBIT Margin (%) | 0.00 | 0.00 | -12020.00 | 172.28 | 28.07 |
| PBT Margin (%) | 0.00 | 0.00 | -12073.33 | -2835.96 | -419.48 |
| Net Profit Margin (%) | 0.00 | 0.00 | -12073.33 | -2834.38 | -418.47 |
| NP After MI And SOA Margin (%) | 0.00 | 0.00 | -11973.33 | -2834.03 | -418.06 |
| Return on Networth / Equity (%) | -49.90 | 5.61 | -23.42 | -170.72 | -81.97 |
| Return on Capital Employeed (%) | -36.01 | 1.13 | -1.16 | 0.61 | 0.73 |
| Return On Assets (%) | -20.94 | 0.37 | -1.01 | -9.25 | -9.88 |
| Long Term Debt / Equity (X) | 0.00 | 0.00 | 0.06 | 0.21 | 0.13 |
| Total Debt / Equity (X) | 1.28 | 0.50 | 0.06 | 0.21 | 0.13 |
| Asset Turnover Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 |
| Current Ratio (X) | 1.72 | 0.73 | 0.71 | 0.84 | 0.74 |
| Quick Ratio (X) | 1.72 | 0.73 | 0.71 | 0.84 | 0.74 |
| Interest Coverage Ratio (X) | -3.08 | 2.75 | -225.38 | 30.28 | 56.89 |
| Interest Coverage Ratio (Post Tax) (X) | -3.08 | 1.98 | -225.38 | 27.53 | 49.26 |
| Enterprise Value (Cr.) | 6.36 | 8.40 | 8.44 | 8.17 | 2.87 |
| EV / Net Operating Revenue (X) | 0.00 | 0.00 | 5623.62 | 143.28 | 6.28 |
| EV / EBITDA (X) | -31.35 | 46.45 | -46.79 | 74.92 | 18.70 |
| MarketCap / Net Operating Revenue (X) | 0.00 | 0.00 | 5618.68 | 139.67 | 5.64 |
| Price / BV (X) | 10.18 | 6.64 | 11.00 | 8.42 | 1.11 |
| Price / Net Operating Revenue (X) | 0.00 | 0.00 | 5716.67 | 140.87 | 5.65 |
| EarningsYield | -0.04 | 0.01 | -0.02 | -0.20 | -0.74 |
After reviewing the key financial ratios for Alchemist Corporation Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is -0.57. This value is below the healthy minimum of 5. It has decreased from 0.13 (Mar 24) to -0.57, marking a decrease of 0.70.
- For Diluted EPS (Rs.), as of Mar 25, the value is -0.57. This value is below the healthy minimum of 5. It has decreased from 0.13 (Mar 24) to -0.57, marking a decrease of 0.70.
- For Cash EPS (Rs.), as of Mar 25, the value is -0.54. This value is below the healthy minimum of 3. It has decreased from 0.13 (Mar 24) to -0.54, marking a decrease of 0.67.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 1.13. It has decreased from 2.39 (Mar 24) to 1.13, marking a decrease of 1.26.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 1.13. It has decreased from 32.28 (Mar 24) to 1.13, marking a decrease of 31.15.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 0.00. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For PBDIT / Share (Rs.), as of Mar 25, the value is -0.41. This value is below the healthy minimum of 2. It has decreased from 0.36 (Mar 24) to -0.41, marking a decrease of 0.77.
- For PBIT / Share (Rs.), as of Mar 25, the value is -0.41. This value is below the healthy minimum of 0. It has decreased from 0.36 (Mar 24) to -0.41, marking a decrease of 0.77.
- For PBT / Share (Rs.), as of Mar 25, the value is -0.54. This value is below the healthy minimum of 0. It has decreased from 0.23 (Mar 24) to -0.54, marking a decrease of 0.77.
- For Net Profit / Share (Rs.), as of Mar 25, the value is -0.54. This value is below the healthy minimum of 2. It has decreased from 0.13 (Mar 24) to -0.54, marking a decrease of 0.67.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is -0.56. This value is below the healthy minimum of 2. It has decreased from 0.13 (Mar 24) to -0.56, marking a decrease of 0.69.
- For PBDIT Margin (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 10. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For PBIT Margin (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 10. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For PBT Margin (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 10. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Net Profit Margin (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 8. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Return on Networth / Equity (%), as of Mar 25, the value is -49.90. This value is below the healthy minimum of 15. It has decreased from 5.61 (Mar 24) to -49.90, marking a decrease of 55.51.
- For Return on Capital Employeed (%), as of Mar 25, the value is -36.01. This value is below the healthy minimum of 10. It has decreased from 1.13 (Mar 24) to -36.01, marking a decrease of 37.14.
- For Return On Assets (%), as of Mar 25, the value is -20.94. This value is below the healthy minimum of 5. It has decreased from 0.37 (Mar 24) to -20.94, marking a decrease of 21.31.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Total Debt / Equity (X), as of Mar 25, the value is 1.28. This value exceeds the healthy maximum of 1. It has increased from 0.50 (Mar 24) to 1.28, marking an increase of 0.78.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.00. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Current Ratio (X), as of Mar 25, the value is 1.72. This value is within the healthy range. It has increased from 0.73 (Mar 24) to 1.72, marking an increase of 0.99.
- For Quick Ratio (X), as of Mar 25, the value is 1.72. This value is within the healthy range. It has increased from 0.73 (Mar 24) to 1.72, marking an increase of 0.99.
- For Interest Coverage Ratio (X), as of Mar 25, the value is -3.08. This value is below the healthy minimum of 3. It has decreased from 2.75 (Mar 24) to -3.08, marking a decrease of 5.83.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is -3.08. This value is below the healthy minimum of 3. It has decreased from 1.98 (Mar 24) to -3.08, marking a decrease of 5.06.
- For Enterprise Value (Cr.), as of Mar 25, the value is 6.36. It has decreased from 8.40 (Mar 24) to 6.36, marking a decrease of 2.04.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For EV / EBITDA (X), as of Mar 25, the value is -31.35. This value is below the healthy minimum of 5. It has decreased from 46.45 (Mar 24) to -31.35, marking a decrease of 77.80.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Price / BV (X), as of Mar 25, the value is 10.18. This value exceeds the healthy maximum of 3. It has increased from 6.64 (Mar 24) to 10.18, marking an increase of 3.54.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For EarningsYield, as of Mar 25, the value is -0.04. This value is below the healthy minimum of 5. It has decreased from 0.01 (Mar 24) to -0.04, marking a decrease of 0.05.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Alchemist Corporation Ltd:
- Net Profit Margin: 0%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: -36.01% (Industry Average ROCE: 13.95%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: -49.9% (Industry Average ROE: 10.65%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): -3.08
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.72
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 157.51)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 1.28
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 0%
Fundamental Analysis of Alchemist Corporation Ltd
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Inorganic - Others | R-4, Unit No. 103, First Floor, New Delhi Delhi 110017 | info@alchemist-corp.com http://www.alchemist-corp.com |
| Management | |
|---|---|
| Name | Position Held |
| Ms. Pooja Rastogi | Managing Director |
| Mr. Kailash | Independent Director |
| Mrs. Meena Rastogi | Non Executive Director |
| Mrs. Sheetal Jain | Non Executive Director |
| Mr. Sanjeev Kumar | Independent Director |
Alchemist Corporation Ltd. Share Price Update | |
|---|---|
| Share Price | Value |
| Today | ₹15.11 |
| Previous Day | ₹15.11 |
FAQ
What is the intrinsic value of Alchemist Corporation Ltd?
Alchemist Corporation Ltd's intrinsic value (as of 26 December 2025) is 0.96 which is 96.35% lower the current market price of 26.30, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 12.9 Cr. market cap, FY2025-2026 high/low of 26.3/10.5, reserves of ₹-4.48 Cr, and liabilities of 0.62 Cr.
What is the Market Cap of Alchemist Corporation Ltd?
The Market Cap of Alchemist Corporation Ltd is 12.9 Cr..
What is the current Stock Price of Alchemist Corporation Ltd as on 26 December 2025?
The current stock price of Alchemist Corporation Ltd as on 26 December 2025 is 26.3.
What is the High / Low of Alchemist Corporation Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Alchemist Corporation Ltd stocks is 26.3/10.5.
What is the Stock P/E of Alchemist Corporation Ltd?
The Stock P/E of Alchemist Corporation Ltd is .
What is the Book Value of Alchemist Corporation Ltd?
The Book Value of Alchemist Corporation Ltd is 0.87.
What is the Dividend Yield of Alchemist Corporation Ltd?
The Dividend Yield of Alchemist Corporation Ltd is 0.00 %.
What is the ROCE of Alchemist Corporation Ltd?
The ROCE of Alchemist Corporation Ltd is 7.45 %.
What is the ROE of Alchemist Corporation Ltd?
The ROE of Alchemist Corporation Ltd is 9.02 %.
What is the Face Value of Alchemist Corporation Ltd?
The Face Value of Alchemist Corporation Ltd is 10.0.